semaglutide and alzheimer's disease Preventative tirzepatide treatment does not alter progression in the 5xFAD mouse model of disease Evaluating Semaglutide for Alzheimer's Disease

FAQs of WEGOVY INJECTION 0.5 mg (Semaglutide): Q: How should WEGOVY INJECTION 0.5 mg be stored for optimal effectiveness

Important safety considerations include risk of acute pancreatitis (seek urgent medical attention for severe, persistent abdominal pain), gallbladder disease, dehydration leading to acute kidney injury with severe gastrointestinal effects, and potential worsening of diabetic retinopathy, particularly with rapid improvement in blood glucose control

A clinical trial published in 2022 found that an older GLP-1 drug called exenatide also reduced drinking among those who had both alcohol use disorder and obesity

Jiao R, Lin C, Cai X, Wang J, Wang Y, Lv F, et al

diabetic neuropathy